Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT
Aug 20, 2026, 17:43

Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT

Moazzam Shahzad, Assistant Professor at University of South Florida and Moffitt Cancer Center, shared a post on X about a recent article he and his colleague co-authored, published in Transplantation and Cellular Therapy, adding:

“Our latest article in Transplantation and Cellular Therapy Journal shows Haplo-HCT with PTCy delivers outcomes comparable to MSD-HCT, supporting its use as a robust alternative when a matched sibling donor is unavailable.”

Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, Board Member of Kansas Society of Clinical Oncology, shared Moazzam Shahzad‘s post on X:

“I’ve said it before, and I’ll say it again:

Muhammad Umair Mushtaq and Moazzam Shahzad could build an entire cancer center and run all its clinical trials by themselves!

These two are unstoppable machines!”

Title: Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis

Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, Muhammad Kashif Amin, Shayan Forghani, Hediyeh Alemi, Naghmeh Khavandgar, Shah Rukh, Khalid Halahleh, Anurag K. Singh, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Moazzam Shahzad

Stay updated on all scientific advnaces with Hemostasis Today.